| Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1 JN Boeckel, V Guarani, M Koyanagi, T Roexe, A Lengeling, ... Proceedings of the National Academy of Sciences 108 (8), 3276, 2011 | 160 | 2011 |
| Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance LA Martin, R Ribas, N Simigdala, E Schuster, S Pancholi, T Tenev, ... Nature communications 8 (1), 1865, 2017 | 156 | 2017 |
| Hypoxia-induced alternative splicing in endothelial cells JE Weigand, JN Boeckel, P Gellert, S Dimmeler Public Library of Science 7 (8), e42697, 2012 | 113 | 2012 |
| Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction K Kreymborg, S Uchida, P Gellert, A Schneider, T Boettger, R Voswinckel, ... Journal of molecular and cellular cardiology 49 (4), 598-605, 2010 | 72 | 2010 |
| A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1 G Militello, MR Hosen, Y Ponomareva, P Gellert, T Weirick, D John, ... Journal of molecular cell biology 10 (2), 102-117, 2018 | 67 | 2018 |
| Noncoder: a web interface for exon array-based detection of long non-coding RNAs P Gellert, Y Ponomareva, T Braun, S Uchida Nucleic acids research 41 (1), e20-e20, 2013 | 53 | 2013 |
| Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation P Gellert, CV Segal, Q Gao, E López-Knowles, LA Martin, A Dodson, T Li, ... Nature communications 7 (1), 13294, 2016 | 38 | 2016 |
| Exon Array Analyzer: a web interface for Affymetrix exon array analysis P Gellert, S Uchida, T Braun Bioinformatics 25 (24), 3323-3324, 2009 | 24 | 2009 |
| C-It: a knowledge database for tissue-enriched genes P Gellert, K Jenniches, T Braun, S Uchida Bioinformatics 26 (18), 2328, 2010 | 23 | 2010 |
| Genetic analysis of the cardiac methylome at single nucleotide resolution in a model of human cardiovascular disease MD Johnson, M Mueller, M Adamowicz-Brice, MJ Collins, P Gellert, ... PLoS genetics 10 (12), e1004813, 2014 | 22 | 2014 |
| Gene Array Analyzer: alternative usage of gene arrays to study alternative splicing events P Gellert, M Teranishi, K Jenniches, P De Gaspari, D John, ... Nucleic acids research 40 (6), 2414-2425, 2012 | 20 | 2012 |
| Functionally conserved noncoding regulators of cardiomyocyte proliferation and regeneration in mouse and human M Adamowicz, CC Morgan, BJ Haubner, M Noseda, MJ Collins, ... Circulation: Genomic and Precision Medicine 11 (2), e001805, 2018 | 19 | 2018 |
| Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations E Lopez-Knowles, A Pearson, G Schuster, P Gellert, R Ribas, B Yeo, ... British journal of cancer 120 (2), 247-255, 2019 | 16 | 2019 |
| A systems immunology approach identifies the collective impact of 5 miRs in Th2 inflammation A Kılıç, M Santolini, T Nakano, M Schiller, M Teranishi, P Gellert, ... JCI insight 3 (11), 2018 | 16 | 2018 |
| Deeply Dissecting Stemness: Making Sense to Non-Coding RNAs in Stem Cells S Uchida, P Gellert, T Braun Stem Cell Reviews and Reports, 1-9, 2011 | 15 | 2011 |
| POETIC Trial Management Group and Trialists Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation P Gellert, CV Segal, Q Gao, E López-Knowles, LA Martin, A Dodson, T Li, ... Nat Commun 7, 13294, 2016 | 7 | 2016 |
| Abstract S6-02: Occurrence of natural ESR1 mutations during acquisition of endocrine resistance in breast cancers and widely used ER+ cell lines P Gellert, R Ribas, S Pancholi, E Lopez-Knowles, B Yeo, I Garcia-Murillas, ... Cancer Research 76 (4_Supplement), S6-02-S6-02, 2016 | 2 | 2016 |
| Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment EF Schuster, P Gellert, CV Segal, E López-Knowles, R Buus, ... JCO Precision Oncology 3, 1-11, 2019 | 1 | 2019 |
| Resistance to Palbociclib involves multiple mechanisms amenable to targeting with drug holidays or drug switching to improve therapeutic outcomes S Pancholi, R Ribas, N Simigdala, A Ressa, J Nikitorowicz-Buniak, Q Gao, ... Investigating molecular factors regulating cancer biology: from proteomics …, 2019 | | 2019 |
| Systems Immunology Identifies the Combined Activity of a Set of MicroRNAs in Shaping the Th2 Phenotype in Allergic Airway Inflammation A Kilic, M Santolini, T Nakano, M Schiller, M Teranishi, P Gellert, ... D92. GENETICS AND GENOMICS OF OBSTRUCTIVE LUNG DISEASE, A7363-A7363, 2018 | | 2018 |
Thomas BraunMax-PlanckVerified email at mpi-BN.MPG.de
